Bipartisan Congressional Briefing “Controlling hepatitis as a global level”
date : 7/27/2012

On the 27 July 2012, the Health and
Global Policy Institute held a ‘Bipartisan Congressional Briefing’ (Diet member
study session) in Meeting Room 6 of Building 1 of the House of Representatives.
The theme of the briefing on this
occasion was ‘Thinking about future integrated approaches for tackling
hepatitis’, and we were delighted to welcome President of the World Hepatitis
Alliance Mr. Charles Gore to speak on some positive global examples. Party
allegiances were put aside for the occasion with participation from various
members of the National Diet who are well acquainted with healthcare and
government administration of medical affairs, together also with individuals
representing patient groups, healthcare establishments and numerous media
outlets.
As one of the most prevalent infectious diseases worldwide, global initiatives to prevent the incidence and spread of viral hepatitis as well as to tackle discrimination and prejudice aimed at patients and infected individuals have been ongoing. Recent years however have seen the implementation of ‘World Hepatitis Day’ by the World Health Organization in 2010, and Japan has now followed on from this development by establishing the first ‘Japan Hepatitis Day’ on the 28 July of this year. As the resulting raise in momentum of integrated approaches for tackling hepatitis occur both domestically and abroad, there is an important opportunity for people involved in this area to think again about future measures, and a lively exchange of opinions took place at the Congressional Briefing.
The Health and Global Policy Institute has previously created similar occasions
for bipartisan discussions to occur between various Diet Members and experts.
These activities will be continued into the future, with the aim of
contributing to the construction of highly transparent processes for the
achievement of more tangibly responsible policies.
Exhibition date:2012-07-27
Top Research & Recommendations Posts
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Public Comment Submission] “GX2040 Vision (Draft)” (January 26, 2025)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Public Comment Submission] “Third Phase of The Healthcare Policy (Draft)” (February 3, 2025)
- [Public Comment Submission] “Plan for Global Warming Countermeasures (Draft)” (January 26, 2025)
- [Publication Report] Guidance on Patient and Public Involvement (PPI) in Health Policymaking: Necessary Initiatives and Good Examples from the Public and Government (March 31, 2024)
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Policy Recommendations] Achieving a Sustainable Society of Health and Longevity Through the Integration of Environment and Healthcare-Incorporating a Planetary Health Perspective into the 3rd Phase of The Healthcare Policy-(December 20, 2024)
Featured Posts
-
2025-02-12
[Registration Open] (Webinar) The 131st HGPI Seminar “The Policy Process of the Kyoto City Caregiver Ordinance” (March 19, 2025)
-
2025-02-20
[Registration Open] The Cardiovascular Disease (CVD) Control Promotion Project Online Global Symposium “Exploring the Future of CVD Control Through Policy Case Studies in the Asia-Pacific Region” (March 13, 2025)
-
2025-03-03
[Registration Open] (Webinar) HGPI Special Seminar “Insights from Harvard Students on Fukushima’s Recover” (March 21, 2025 EDT | March 22, 2025 JST)
-
2025-03-13
[HGPI Policy Column] (No.54) From the Kidney Disease Control Promotion Project “The Promotion of Kidney Disease Measures Through Multi-Stakeholder Collaboration”
-
2025-03-13
[HGPI Policy Column] (No.55) From the Kidney Disease Control Promotion Project “What Is Required from a Patient Perspective for Continuity of Treatment for Chronic Kidney Disease (CKD): Dietary Therapy Edition”